Literature DB >> 3685247

Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews.

A Zimran1, B Rudensky, M R Kramer, F Tedesco, M Ehrenfeld, R Raz, Z Greif, M Gelber, M Lishner, E Golan.   

Abstract

The prevalence of complement deficiency was studied among 111 survivors of sporadic meningococcal disease located through the medical records of 10 Israeli hospitals. There were 11 patients with CH50 = 0: one with systemic lupus erythematosus and 10 with hereditary terminal complement deficiency (four with homozygous C7 and six with C8 deficiency). There was no hereditary complement deficiency among 39 Ashkenazi subjects as against 18 per cent among 38 Sephardi subjects and 40 per cent among 15 of Moroccan ancestry (p less than 0.05). The age at first presentation of meningococcal disease in complement deficient patients was 14.7 +/- 7.6, years compared with 8.1 +/- 10.9 in the non-deficient patients (p less than 0.025). None of the complement deficient patients had meningitis below the age of 5 years vs. 49 per cent of non-deficient subjects. Recurrent meningitis was observed in 40 vs. 4 per cent (p less than 0.01) and meningitis in siblings in 40 vs. 2 per cent respectively (p less than 0.001). In addition to the 10 propositi, 11 non-propositus siblings were identified with severe complement deficiency (six with homozygous C7 and five with C8 deficiency). Seven of the non-propositi had no history at all of meningitis or any other serious systemic disease, underlining the relatively favourable prognosis of terminal complement deficiency. With increasing familiarity with the clinical features of this hereditary disease, it is possible now to identify on clinical grounds patients with meningococcal disease with a high likelihood of terminal complement deficiency.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3685247

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections.

Authors:  M Schlesinger; Z Nave; Y Levy; P E Slater; Z Fishelson
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

2.  Two distinct abnormalities in patients with C8 alpha-gamma deficiency. Low level of C8 beta chain and presence of dysfunctional C8 alpha-gamma subunit.

Authors:  F Tedesco; L Roncelli; B H Petersen; V Agnello; J M Sodetz
Journal:  J Clin Invest       Date:  1990-09       Impact factor: 14.808

3.  Two novel mutations in the C7 gene in a Korean patient with complement C7 deficiency.

Authors:  Chang-Seok Ki; Jong-Won Kim; Hee-Jin Kim; Sung-Min Choi; Gyoung-Yim Ha; Hee Jung Kang; Won-Duck Kim
Journal:  J Korean Med Sci       Date:  2005-04       Impact factor: 2.153

Review 4.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Complement component deficiencies and infection: C5, C8 and C3 deficiencies in three families.

Authors:  O Sanal; M Loos; F Ersoy; G Kanra; G Seçmeer; I Tezcan
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

6.  Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.

Authors:  E Leitersdorf; A Reshef; V Meiner; R Levitzki; S P Schwartz; E J Dann; N Berkman; J J Cali; L Klapholz; V M Berginer
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

7.  Gene responsible for deficient activity of the beta subunit of C8, the eighth component of complement, is located on mouse chromosome 4.

Authors:  S Tanaka; T Suzuki; M Sakaizumi; Y Harada; Y Matsushima; N Miyashita; Y Fukumori; S Inai; K Moriwaki; H Yonekawa
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

8.  Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping.

Authors:  L J Egan; A Orren; J Doherty; R Würzner; C F McCarthy
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

9.  Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).

Authors:  Waleed Al-Herz
Journal:  J Clin Immunol       Date:  2007-11-16       Impact factor: 8.317

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.